{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:33:49Z","timestamp":1790188429971,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:00:00Z","timestamp":1538611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"INRSP","award":["004\/02CT\/2011\/INRSP\/DG"],"award-info":[{"award-number":["004\/02CT\/2011\/INRSP\/DG"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/jac\/dky382","type":"journal-article","created":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T19:16:49Z","timestamp":1537989409000},"page":"165-171","source":"Crossref","is-referenced-by-count":9,"title":["Impact of HIV-1 primary drug resistance on the efficacy of a first-line antiretroviral regimen in the blood of newly diagnosed individuals in Bamako, Mali"],"prefix":"10.1093","volume":"74","author":[{"given":"Abdelaye","family":"Keita","sequence":"first","affiliation":[{"name":"Institut National de Recherche en Sant\u00e9 Publique (INRSP), Bamako, Mali"},{"name":"Groupe Immunit\u00e9 des Muqueuses et Agents Pathog\u00e8nes GIMAP EA3064, University of Saint-Etienne, University of Lyon, Saint-Etienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssouf","family":"Sereme","sequence":"additional","affiliation":[{"name":"Groupe Immunit\u00e9 des Muqueuses et Agents Pathog\u00e8nes GIMAP EA3064, University of Saint-Etienne, University of Lyon, Saint-Etienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Pillet","sequence":"additional","affiliation":[{"name":"Groupe Immunit\u00e9 des Muqueuses et Agents Pathog\u00e8nes GIMAP EA3064, University of Saint-Etienne, University of Lyon, Saint-Etienne, France"},{"name":"Laboratoire des Agents Infectieux et d\u2019Hygi\u00e8ne, University Hospital of Saint-Etienne, Saint Etienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souleymane","family":"Coulibaly","sequence":"additional","affiliation":[{"name":"Institut National de Recherche en Sant\u00e9 Publique (INRSP), Bamako, Mali"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fodi\u00e9","family":"Diallo","sequence":"additional","affiliation":[{"name":"Centre d\u2019\u00e9coute de soins et d\u2019accompagnement (CESAC), Bamako, Mali"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pozzetto","sequence":"additional","affiliation":[{"name":"Groupe Immunit\u00e9 des Muqueuses et Agents Pathog\u00e8nes GIMAP EA3064, University of Saint-Etienne, University of Lyon, Saint-Etienne, France"},{"name":"Laboratoire des Agents Infectieux et d\u2019Hygi\u00e8ne, University Hospital of Saint-Etienne, Saint Etienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenin Aoua","family":"Thiero","sequence":"additional","affiliation":[{"name":"Institut National de Recherche en Sant\u00e9 Publique (INRSP), Bamako, Mali"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bourlet","sequence":"additional","affiliation":[{"name":"Groupe Immunit\u00e9 des Muqueuses et Agents Pathog\u00e8nes GIMAP EA3064, University of Saint-Etienne, University of Lyon, Saint-Etienne, France"},{"name":"Laboratoire des Agents Infectieux et d\u2019Hygi\u00e8ne, University Hospital of Saint-Etienne, Saint Etienne, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,4]]},"reference":[{"key":"key\n\t\t\t\t2018121401543006600_dky382-B1","author":"UNAIDS"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B2","author":"UNAIDS"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B3","author":"World Health Organization"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B4","doi-asserted-by":"crossref","first-page":"e000227.","DOI":"10.1136\/bmjgh-2016-000227","article-title":"UNAIDS 90-90-90 targets to end the AIDS epidemic by 2020 are not realistic: comment on \u201cCan the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades\u201d","volume":"2","author":"Bain","year":"2017","journal-title":"BMJ Glob Health"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1089\/aid.2016.0010","article-title":"Short communication: high viral load and multidrug resistance due to late switch to second-line regimens could be a major obstacle to reach the 90-90-90 UNAIDS objectives in sub-Saharan Africa","volume":"32","author":"Guichet","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/09540121.2010.498867","article-title":"Switch to second-line ART in Western Africa routine care: incidence and reasons for switching","volume":"23","author":"Landier","year":"2011","journal-title":"AIDS Care"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/COH.0b013e32835b7f94","article-title":"Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa","volume":"8","author":"Hamers","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/cid\/cit627","article-title":"Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-Saharan Africa and southeast Asia","volume":"58","author":"Aghokeng","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B9","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/QAD.0000000000000906","article-title":"Alarming rates of virological failure and drug resistance in patients on long-term antiretroviral treatment in routine HIV clinics in Togo","volume":"29","author":"Konou","year":"2015","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/aid.2012.0118","article-title":"Transmitted antiretroviral drug resistance in newly HIV-infected and untreated patients in Segou and Bamako, Mali","volume":"29","author":"Maiga","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/135965350801302S04","article-title":"Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment","volume":"13","author":"Bennett","year":"2008","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-3156.2010.02505.x","article-title":"Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centers","volume":"15","author":"Ekouevi","year":"2010","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12889-018-5208-0","article-title":"Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey","volume":"18","author":"Huerga","year":"2018","journal-title":"BMC Public Health"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0899-9007(99)00210-5","article-title":"Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients","volume":"15","author":"Melchior","year":"1999","journal-title":"Nutrition"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/hiv.12533","article-title":"Out of focus: tailoring the cascade of care to the needs of women living with HIV","volume":"18","author":"Geretti","year":"2017","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/hiv.12203","article-title":"Gender inequalities in the response to combination antiretroviral therapy over time: the Swiss HIV Cohort Study","volume":"16","author":"Rosin","year":"2015","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11904-011-0098-0","article-title":"Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011","volume":"8","author":"Puskas","year":"2011","journal-title":"Curr HIV\/AIDS Rep"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/09540121.2017.1394436","article-title":"Acceptability and feasibility of a financial incentive intervention to improve retention in HIV care among pregnant women in Johannesburg, South Africa","volume":"30","author":"Clouse","year":"2018","journal-title":"AIDS Care"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B19","author":"World Health Organization","year":"2017"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/135965350601100511","article-title":"HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon","volume":"11","author":"Vergne","year":"2006","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/jac\/dkn234","article-title":"Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006","volume":"62","author":"Derache","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1468-1293.2009.00806.x","article-title":"High level of primary drug resistance in Mali","volume":"11","author":"Haidara","year":"2010","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B23","volume-title":"Guidelines on the Public Health Response to Pretreatment HIV Drug Resistance","author":"WHO","year":"2017"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B24","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/S2352-3018(17)30190-X","article-title":"Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study","volume":"5","author":"Phillips","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B25","doi-asserted-by":"crossref","first-page":"e95956.","DOI":"10.1371\/journal.pone.0095956","article-title":"First line treatment response in patients with transmitted HIV drug resistance and well defined timepoint of HIV infection: updated results from the German HIV-1 seroconverter study","volume":"9","author":"Zu Knyphausen","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","article-title":"Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study","volume":"11","author":"Wittkop","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B27","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1097\/INF.0000000000001575","article-title":"High rates of baseline drug resistance and virological failure among ART-naive HIV-infected children in Mali","volume":"36","author":"Crowell","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/QAI.0b013e3182a009e4","article-title":"Increasing rate of TAMs and etravirine resistance in HIV-1-infected adults between 12 and 24 months of treatment: the VOLTART cohort study in C\u00f4te d\u2019Ivoire, West Africa","volume":"64","author":"Messou","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2018121401543006600_dky382-B29","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1093\/jac\/dks310","article-title":"Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting","volume":"67","author":"Maiga","year":"2012","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/1\/165\/27124596\/dky382.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T20:19:22Z","timestamp":1720642762000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/1\/165\/5115408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,4]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,10,4]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dky382","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,10,4]]}}}